Cas:1397836-49-5 2-ethoxy-1-{[2′-(N’-hydroxycarbamimidoyl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid manufacturer & supplier

Chemical Name:2-ethoxy-1-{[2′-(N’-hydroxycarbamimidoyl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid

CAS.NO:1397836-49-5

Synonyms:2-ethoxy-1-{[2′-(N-hydroxycarbamimidoyl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid;2-Ethoxy-1-{[2′-(N-hydroxycarbamimidoyl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylic acid;2-ethoxy-1-((2′-((hydroxyimino)(amino)methyl)biphenyl-4-yl)methyl)-1H-benzo-[d]imidazole-7-carboxylic acid;1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2′-[(hydroxyamino)iminomethyl][1,1′-biphenyl]-4-yl]methyl]-;2-ethoxy-1-((2′-((hydroxyamino)iminomethyl)biphenyl-4-yl)methyl)-1H-benzo-[d]imidazole-7-carboxylate

Molecular Formula:C₂₄H₂₂N₄O₄

Molecular Weight:430.456

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:741.2±70.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.667

PSA:122.96000

Exact Mass:430.164093

LogP:4.52

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-ethoxy-1-{[2′-(N-hydroxycarbamimidoyl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-ethoxy-1-((2′-((hydroxyamino)iminomethyl)biphenyl-4-yl)methyl)-1H-benzo-[d]imidazole-7-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-ethoxy-1-((2′-((hydroxyamino)iminomethyl)biphenyl-4-yl)methyl)-1H-benzo-[d]imidazole-7-carboxylate Use and application,1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2′-[(hydroxyamino)iminomethyl][1,1′-biphenyl]-4-yl]methyl]- technical grade,usp/ep/jp grade.

Related News: With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. 2-ethoxy-1-{[2′-(N’-hydroxycarbamimidoyl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid manufacturer Countries and territories that have confirmed cases: Thailand, Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia, France, the United States, South Korea, Germany, the United Arab Emirates, Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri Lanka, Finland, Sweden and Spain. 2-ethoxy-1-{[2′-(N’-hydroxycarbamimidoyl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS). 2-ethoxy-1-{[2′-(N’-hydroxycarbamimidoyl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid vendor Countries and territories that have confirmed cases: Thailand, Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia, France, the United States, South Korea, Germany, the United Arab Emirates, Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri Lanka, Finland, Sweden and Spain. 2-ethoxy-1-{[2′-(N’-hydroxycarbamimidoyl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid factory Fate Therapeutics�� iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.